S504 • OFID 2019:6 (Suppl 2) • Poster Abstracts other NTM isolates. Most patients (n = 410, 62.8%) had none of the evaluated comorbidities prior to NTM diagnosis. Median follow-up time was 1252 days (IQR 449-2688). Median survival in our cohort among persons with and without comorbidities was 1973 days (95% CI 1487-2995) and 3952 days (95% CI 3496-5186), respectively. Median expected survival in the demographically-matched population cohort was significantly longer at 5479 days (P<.0001). Mortality at 5 years was 47.9% (39.7-55.0) and 27.2% (95% CI 22.1-32.0) among NTM patients with and without comorbidities, respectively, vs. expected mortality of 5.7% in the general population.
